256 related articles for article (PubMed ID: 36116159)
1. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
[TBL] [Abstract][Full Text] [Related]
2. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
3. CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.
Wong TL; Ng KY; Tan KV; Chan LH; Zhou L; Che N; Hoo RLC; Lee TK; Richard S; Lo CM; Man K; Khong PL; Ma S
Hepatology; 2020 Apr; 71(4):1279-1296. PubMed ID: 31469916
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity.
Fei M; Li X; Liang S; Zhou S; Wu H; Sun L; Liu Y; Hu Q; Liu L; Wang J
Cancer Lett; 2024 Mar; 584():216620. PubMed ID: 38218456
[TBL] [Abstract][Full Text] [Related]
5. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
[No Abstract] [Full Text] [Related]
6. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
Yang W; Liu J; Hou L; Chen Q; Liu Y
Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
[TBL] [Abstract][Full Text] [Related]
7. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326/PKM2 axis.
Wang Y; Yang F; Peng Q; Mei K; He H; Yang Q
J Gene Med; 2022 Aug; 24(8):e3440. PubMed ID: 35816558
[TBL] [Abstract][Full Text] [Related]
9. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
[TBL] [Abstract][Full Text] [Related]
10. PKM2 promotes cell metastasis and inhibits autophagy via the JAK/STAT3 pathway in hepatocellular carcinoma.
Yu Z; Wang D; Tang Y
Mol Cell Biochem; 2021 May; 476(5):2001-2010. PubMed ID: 33512635
[TBL] [Abstract][Full Text] [Related]
11. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X
Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447
[TBL] [Abstract][Full Text] [Related]
13. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
Martin SP; Fako V; Dang H; Dominguez DA; Khatib S; Ma L; Wang H; Zheng W; Wang XW
J Exp Clin Cancer Res; 2020 Jun; 39(1):99. PubMed ID: 32487192
[TBL] [Abstract][Full Text] [Related]
14. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.
Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X
Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233
[TBL] [Abstract][Full Text] [Related]
15. PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition.
Yang Y; Ren P; Liu X; Sun X; Zhang C; Du X; Xing B
J Exp Clin Cancer Res; 2022 Mar; 41(1):101. PubMed ID: 35292107
[TBL] [Abstract][Full Text] [Related]
16. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
[No Abstract] [Full Text] [Related]
17. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
18. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM
PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
[TBL] [Abstract][Full Text] [Related]
19. Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.
Jung Y; Jang YJ; Kang MH; Park YS; Oh SJ; Lee DC; Xie Z; Yoo HS; Park KC; Yeom YI
Mol Cells; 2013 Apr; 35(4):335-41. PubMed ID: 23515579
[TBL] [Abstract][Full Text] [Related]
20. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment.
Zhang J; Ouyang F; Gao A; Zeng T; Li M; Li H; Zhou W; Gao Q; Tang X; Zhang Q; Ran X; Tian G; Quan X; Tang Z; Zou J; Zeng Y; Long Y; Li Y
Mol Cancer; 2024 May; 23(1):94. PubMed ID: 38720298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
